PTC THERAPEUTICS INC's ticker is PTCT and the CUSIP is 69366J200. A total of 121 filers reported holding PTC THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.38 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $19,000 | -60.4% | 391 | -71.9% | 0.00% | – |
| Q3 2019 | $48,000 | -23.8% | 1,392 | -0.1% | 0.00% | – |
| Q2 2019 | $63,000 | +21.2% | 1,393 | -0.1% | 0.00% | – |
| Q1 2019 | $52,000 | +300.0% | 1,395 | +283.2% | 0.00% | – |
| Q4 2018 | $13,000 | -23.5% | 364 | -0.8% | 0.00% | – |
| Q3 2018 | $17,000 | +41.7% | 367 | -15.0% | 0.00% | – |
| Q2 2018 | $12,000 | 0.0% | 432 | 0.0% | 0.00% | – |
| Q1 2018 | $12,000 | +50.0% | 432 | -1.1% | 0.00% | – |
| Q4 2017 | $8,000 | -55.6% | 437 | -52.6% | 0.00% | – |
| Q3 2017 | $18,000 | -91.1% | 922 | -91.6% | 0.00% | -100.0% |
| Q2 2017 | $202,000 | +94.2% | 11,029 | +4.8% | 0.00% | +100.0% |
| Q1 2017 | $104,000 | +3366.7% | 10,521 | +4211.9% | 0.00% | – |
| Q4 2016 | $3,000 | -25.0% | 244 | -11.9% | 0.00% | – |
| Q3 2016 | $4,000 | +100.0% | 277 | 0.0% | 0.00% | – |
| Q2 2016 | $2,000 | 0.0% | 277 | -4.2% | 0.00% | – |
| Q1 2016 | $2,000 | -80.0% | 289 | -7.4% | 0.00% | – |
| Q4 2015 | $10,000 | +25.0% | 312 | +2.6% | 0.00% | – |
| Q3 2015 | $8,000 | – | 304 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 1,750,000 | $84,053,000 | 7.32% |
| RTW INVESTMENTS, LP | 3,832,480 | $184,074,000 | 6.94% |
| Burrage Capital Management LLC | 195,725 | $9,401,000 | 6.30% |
| Asymmetry Capital Management, L.P. | 55,408 | $2,661,000 | 4.77% |
| SECTORAL ASSET MANAGEMENT INC | 328,738 | $15,789,000 | 2.36% |
| ARMISTICE CAPITAL, LLC | 758,000 | $36,407,000 | 2.10% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 114,000 | $5,470,000 | 1.97% |
| Opaleye Management Inc. | 191,000 | $9,174,000 | 1.80% |
| Sofinnova Investments, Inc. | 517,092 | $24,836,000 | 1.79% |
| Chubb Ltd | 8,180 | $393,000 | 1.68% |